Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page
25
Current page
7
SC 13D/A File 005-42217

SC 13D/A

Filing date
07 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Sep 2023
Reporting date
28 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-42217

SCHEDULE 13G

Filing date
28 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
25 Aug 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-273977

424B3

Filing date
23 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-273977

EFFECT filing

Filing date
22 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
17 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-273977

S-3

Filing date
14 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Aug 2023
Reporting date
08 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Aug 2023
Reporting date
08 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42217

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
26 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-487908

D filing

Filing date
26 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-487907

D filing

Filing date
26 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-42217

SC 13G/A

Filing date
21 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2023
Reporting date
14 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2023
Reporting date
14 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jul 2023
Reporting date
14 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
11 Jul 2023
Reporting date
06 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .